[HTML][HTML] Regulation of NFATc1 in osteoclast differentiation

JH Kim, N Kim - Journal of bone metabolism, 2014 - ncbi.nlm.nih.gov
JH Kim, N Kim
Journal of bone metabolism, 2014ncbi.nlm.nih.gov
Osteoclasts are unique cells that degrade the bone matrix. These large multinucleated cells
differentiate from the monocyte/macrophage lineage upon stimulation by two essential
cytokines, macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear
factor-kappa B (NF-κB) ligand (RANKL). Activation of transcription factors such as
microphthalmia transcription factor (MITF), c-Fos, NF-κB, and nuclear factor-activated T cells
c1 (NFATc1) is required for sufficient osteoclast differentiation. In particular, NFATc1 plays …
Abstract
Osteoclasts are unique cells that degrade the bone matrix. These large multinucleated cells differentiate from the monocyte/macrophage lineage upon stimulation by two essential cytokines, macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B (NF-κB) ligand (RANKL). Activation of transcription factors such as microphthalmia transcription factor (MITF), c-Fos, NF-κB, and nuclear factor-activated T cells c1 (NFATc1) is required for sufficient osteoclast differentiation. In particular, NFATc1 plays the role of a master transcription regulator of osteoclast differentiation. To date, several mechanisms, including transcription, methylation, ubiquitination, acetylation, and non-coding RNAs, have been shown to regulate expression and activation of NFATc1. In this review, we have summarized the various mechanisms that control NFATc1 regulation during osteoclast differentiation.
ncbi.nlm.nih.gov